Company intelligence / Profile preview
Trexapharm
Lagos, Lagos, Nigeriatrexapharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Trexapharm is a pharmaceutical company based in Nigeria that specializes in the marketing, sales, and distribution of a diverse range of healthcare products. The company's portfolio primarily features branded generic antibiotics, including Trexaclav (amoxicillin/clavulanate) and Trexacef (cefuroxime), alongside nutritional supplements and over-the-counter medications. Trexapharm focuses on providing affordable and high-quality therapeutic solutions to the West African market, partnering with international manufacturers to supply essential medicines. The company operates as a commercial-stage entity with a strong presence in the Nigerian pharmaceutical retail and hospital sectors.
- Therapeutic areas
- Infectious DiseasesMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Trexapharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trexapharm.